OPCU Newsletter
-
09.10.26 -- OPCU Capabilities: Nanoparticles & Solid Dose Formulation Insights
9/10/2026
09/10/26
-
08.28.26 -- Building A More Scalable Cell Line Development Program
8/28/2026
08/28/26 Outsourced Pharma Newsletter
-
08.25.26 -- CDMO Capabilities That Drive Large Molecule Fill/Finish Success
8/25/2026
08/25/26 Outsourced Pharma Newsletter
-
08.19.26 -- OPCU: Capabilities For Choosing The Right CDMO For Gene Therapy Success
8/19/2026
08/19/26 Outsourced Pharma Newsletter
-
07.08.26 -- OPCU: Capabilities For Scaling Advanced Therapeutics
7/8/2026
07/08/26 Outsourced Pharma Newsletter
-
07.07.26 -- Advancing Microbial Manufacturing And ADCs With CDMO Expertise
7/7/2026
07/07/26 Outsourced Pharma Newsletter
-
06.16.26 -- From Biologics To Combination Products: Explore CDMO Capabilities
6/16/2026
06/16/26 Outsourced Pharma Newsletter
-
05.13.26 -- Drug Product Development: Inside CDMO Capabilities That Matter
5/13/2026
05/13/26 Outsourced Pharma Newsletter
-
04.16.26 -- Watch Now: Small Molecule Capabilities That Matter
4/16/2026
04/16/26 Outsourced Pharma Newsletter
-
04.15.26 -- Where Cell & Gene Manufacturing and Analytics Are Expanding
4/15/2026
04/15/26 Outsourced Pharma Newsletter